5-methylcytosine has been researched along with Hodgkin Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkan, S; Huang, Q; Lim, W; McCormack, C; Siref, A | 1 |
| Ambinder, RF; Gulley, ML; Manns, A; Robertson, KD; Swinnen, LJ; Zong, JC | 1 |
2 other study(ies) available for 5-methylcytosine and Hodgkin Disease
| Article | Year |
|---|---|
Diminished expression of 5hmc in Reed-Sternberg cells in classical Hodgkin lymphoma is a common epigenetic marker.
Topics: 5-Methylcytosine; Biomarkers; DNA Methylation; Epigenesis, Genetic; Hodgkin Disease; Humans; Reed-Sternberg Cells | 2020 |
CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
Topics: 5-Methylcytosine; Anemia, Aplastic; Burkitt Lymphoma; CpG Islands; Cytosine; DNA (Cytosine-5-)-Methyltransferases; DNA-Binding Proteins; DNA, Neoplasm; DNA, Viral; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Ghana; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Immunocompromised Host; Immunodominant Epitopes; Immunologic Surveillance; Lymphoma, B-Cell; Methylation; Neoplasm Proteins; Promoter Regions, Genetic; Tumor Virus Infections; Virus Latency | 1996 |